Cardiovascular Risk Management: An Overview

  • Andrea Boni
  • Roberto Lorenzoni
  • Mauro Lazzari
  • Cristina Gemignani
  • Francesco Bovenzi


Cardiovascular disease (CVD) is a leading cause of mortality and is responsible for one-third of all global deaths annually. This translates into the deaths of 17 million people each year [1, 2]. Despite research-based gains in the treatment of CVDs, they remain the leading killer in the USA and in most developed areas of the world. Coronary heart disease (CHD) accounts for the majority of CVD deaths, disproportionately afflicts racial and ethnic minorities, and is a prime target for prevention. Hypertension is the most prevalent CVD, affecting at least 600 million people, and is an important contributor to cardiovascular mortality and morbidity [3]. Nearly 85% of the global mortality and disease burden from CVD is borne by low- and middle-income countries.


Impaired Glucose Regulation Single Risk Factor Audit Standard mmHg Diastolic mmHg Systolic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mathers CD, Stein C, Ma Fat DM et al (2002) Global burden of disease 2000. Version 2: methods and results. World Health Organization, GenevaGoogle Scholar
  2. 2.
    World Health Organization (2002) The World Health Report 2002 ‘Reducing risks and promoting healthy life’. World Health Organization, GenevaGoogle Scholar
  3. 3.
    Mensah GA (2002) The global burden of hypertension: good news and bad news. Cardiol Clin 20(2):181–185PubMedCrossRefGoogle Scholar
  4. 4.
    Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104:2746–2753PubMedCrossRefGoogle Scholar
  5. 5.
    Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104:2855–2864PubMedCrossRefGoogle Scholar
  6. 6.
    Alwan A, Maclean D, Mandil A (2001) Assessment of national capacity for noncom-municable disease prevention and control. The report of a global survey. World Health Organization, GenevaGoogle Scholar
  7. 7.
    World Health Organization (2001) Innovative care for chronic conditions. World Health Organization, GenevaGoogle Scholar
  8. 8.
    Klungel OH, de Boer A, Paes AH et al (1998) Undertreatment of hypertension in a population-based study in the Netherlands. J Hypertens 9:1371–1377CrossRefGoogle Scholar
  9. 9.
    Hedner T (1998) Treating hypertension — effect of treatment and cost-effectiveness in respect to later cardiovascular diseases. Scand Cardiovasc J 47:S31–S35CrossRefGoogle Scholar
  10. 10.
    Trilling JS, Froom J (2000) The urgent need to improve hypertension care. Arch Fam Med 9:794–801PubMedCrossRefGoogle Scholar
  11. 11.
    Pocock SJ, McCormack V, Gueyffier F et al (2001) A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001 323:75–81PubMedCrossRefGoogle Scholar
  12. 12.
    World Health Organization (2001) Adherence to long-term therapies: policy for action. World Health Organization, GenevaGoogle Scholar
  13. 13.
    Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A (1998) Adherence to pharmacologic management of hypertension. Can J Public Health 89(5):116–118Google Scholar
  14. 14.
    Van Den Hoogen PCW, Feskens EJM, Nagelkerke NJD et al for the Seven Countries Study Research Group (2000) The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 342:1–8PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Andrea Boni
    • 1
  • Roberto Lorenzoni
    • 1
  • Mauro Lazzari
    • 1
  • Cristina Gemignani
    • 1
  • Francesco Bovenzi
    • 1
  1. 1.Division of CardiologyCampo di Marte HospitalLuccaItaly

Personalised recommendations